Amphastar Pharmaceuticals, Inc. (AMPH)
19.34
-1.10
(-5.38%)
USD |
NASDAQ |
Mar 06, 16:00
19.24
-0.10
(-0.52%)
After-Hours: 20:00
Amphastar Pharmaceuticals Cash from Investing (Quarterly) : -60.57M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -2.802B |
| Organon & Co. | -65.00M |
| Catalyst Pharmaceuticals, Inc. | -0.032M |
| Johnson & Johnson | -4.485B |
| Pfizer Inc. | -6.146B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 32.86M |
| Cash from Financing (Quarterly) | -18.37M |
| Free Cash Flow | 118.98M |
| Free Cash Flow Per Share (Quarterly) | 0.5214 |
| Free Cash Flow to Equity (Quarterly) | 25.36M |
| Free Cash Flow to Firm (Quarterly) | 29.67M |
| Free Cash Flow Yield | 12.76% |